Tirzepatide is a weekly injection that targets two receptors: GLP-1 and GIP. It slows digestion and reduces hunger through two separate pathways. Brand names include Mounjaro and Zepbound.

Liraglutide is a daily injection that targets only the GLP-1 receptor. It slows stomach emptying and reduces hunger. Brand names include Victoza and Saxenda.

Which one do people choose for weight loss?

Most people choose tirzepatide when maximum weight loss is the goal. Liraglutide is chosen when someone is already stable on it or prefers a daily injection schedule. This is general guidance, not personalized medical advice.

Tirzepatide vs Liraglutide: Which Drops More Weight?

Q: How do tirzepatide and liraglutide work differently?

Tirzepatide targets GLP-1 and GIP receptors at the same time. Liraglutide targets GLP-1 only. Tirzepatide is injected once a week; liraglutide is injected once a day. Clinical trials show tirzepatide produces larger average weight loss [verify: source].

Built by medical professionals, gym rats, and experienced biohackers

Tirzepatide drops more weight than liraglutide because it targets two hunger-regulating receptors instead of one.

Quick Answer
Tirzepatide is for people who want the largest possible weight loss from this class of drug. Liraglutide is for people who prefer a daily routine or have been on it long-term without problems. The verdict: tirzepatide wins on weight loss numbers in head-to-head clinical data .

What Is Tirzepatide?

Tirzepatide (brand names Mounjaro and Zepbound) is a weekly injection that copies two gut hormones. These are glucagon-like peptide 1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP).

Hitting both receptors slows digestion and reduces hunger through two separate pathways at once. It received FDA approval for type 2 diabetes in 2022 and for weight loss in 2023 .

What Is Liraglutide?

Liraglutide (brand names Victoza and Saxenda) is a daily injection that copies only GLP-1.

It slows how fast your stomach empties food, which makes you feel full sooner and longer. Liraglutide has been FDA-approved for type 2 diabetes since 2010 and for weight management since 2014 .

How Do Tirzepatide and Liraglutide Work Differently?

The biggest gap between these two is how many receptors they hit.

Tirzepatide acts on GLP-1 and GIP at the same time. Liraglutide acts on GLP-1 only. This dual action is the main reason tirzepatide produces larger weight loss results in clinical studies .

Mechanism: Tirzepatide copies two gut hormones; liraglutide copies one.

Primary use: Both are approved for type 2 diabetes and obesity.

Typical research dose:
- Tirzepatide: 2.5 mg to 15 mg per week
- Liraglutide: 1.2 mg to 3.0 mg per day

Onset: Most people notice reduced appetite within the first 1 to 2 weeks on either drug. Individual results vary.

Evidence level: Tirzepatide Phase 3 trials showed up to roughly 20% body weight loss at the highest dose . Liraglutide trials showed roughly 5 to 8% weight loss . Both have established safety profiles. Tirzepatide has fewer years of post-market data, so long-term effects are still being monitored.

If you are tracking your injection schedule and weekly weight changes, DoseVault is built for this. Log doses, timing, and body measurements in one place to spot what is and is not working.

How Do Tirzepatide and Liraglutide Compare Side by Side?

Feature	Tirzepatide	Liraglutide
Receptor targets	GLP-1 and GIP	GLP-1 only
Injection frequency	Once a week	Once a day
Max studied dose	15 mg per week	3.0 mg per day
Average weight loss in trials	Roughly 15 to 20%	Roughly 5 to 8%
FDA approval for weight loss	Yes, 2023	Yes, 2014
Post-market track record	Fewer years	More years

Which One Do People Pick, and When?

Most people pick tirzepatide when weight loss is the main goal. The clinical numbers are larger than what liraglutide shows in trials .

Liraglutide is picked when someone is already on it and doing well. Some people also prefer a daily injection routine over a weekly one. Cost and insurance coverage also play a big role in this decision for many people.

This is general decision guidance. It is not personalized medical advice. Talk to a licensed clinician before starting, changing, or stopping any drug.

Disclaimer

This page is for educational purposes only. It is not medical advice. Nothing here should be used to diagnose, treat, cure, or prevent any condition. Always consult a qualified healthcare provider before starting any medication or changing your current protocol.

Built by medical professionals, gym rats, and experienced biohackers

Track your tirzepatide or liraglutide protocol with DoseVault, a tool built for logging weight-loss drug schedules and tracking how your body responds week over week.